Dynamic Technology Lab Private LTD Apellis Pharmaceuticals, Inc. Transaction History

Dynamic Technology Lab Private LTD

  • $914 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$35.07 - $59.21 $188,325 - $317,957
5,370 New
5,370 $243,000
Q4 2018

Feb 13, 2019
SELL
$11.47 - $18.71 $288,631 - $470,818
-25,164 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$16.57 - $21.03 $416,967 - $529,198
25,164 New
25,164 $447,000

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.64B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email